Guardant Health Inc (NASDAQ: GH) is 53.88% higher on its value in year-to-date trading and has touched a low of $20.14 and a high of $53.42 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GH stock was last observed hovering at around $48.09 in the last trading session, with the day’s loss setting it -0.28%.
Currently trading at $47.81, the stock is -4.44% and 4.30% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.51 million and changing -0.58% at the moment leaves the stock 22.96% off its SMA200. GH registered 56.50% gain for a year compared to 6-month gain of 25.49%. The firm has a 50-day simple moving average (SMA 50) of $45.8336 and a 200-day simple moving average (SMA200) of $38.6283.
The stock witnessed a -3.00% loss in the last 1 month and extending the period to 3 months gives it a 5.87%, and is -6.33% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.64% over the week and 4.15% over the month.
Guardant Health Inc (GH) has around 2021 employees, a market worth around $5.92B and $774.00M in sales. Profit margin for the company is -53.82%. Distance from 52-week low is 137.39% and -10.50% from its 52-week high. The company has generated returns on investments over the last 12 months (-40.60%).
The EPS is expected to grow by 23.80% this year
464.0 institutions hold shares in Guardant Health Inc (GH), with institutional investors hold 102.38% of the company’s shares. The shares outstanding are 123.65M, and float is at 117.75M with Short Float at 7.95%. Institutions hold 97.67% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 11.64 million shares valued at $336.07 million. The investor’s holdings represent 9.5035 of the GH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.24 million shares valued at $324.55 million to account for 9.1777 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 6.09 million shares representing 4.9763 and valued at over $175.97 million, while DEEP TRACK CAPITAL, LP holds 3.6751 of the shares totaling 4.5 million with a market value of $129.96 million.
Guardant Health Inc (GH) Insider Activity
The most recent transaction is an insider sale by Talasaz AmirAli, the company’s Co-Chief Executive Officer. SEC filings show that Talasaz AmirAli sold 100,000 shares of the company’s common stock on Jul 01 ’25 at a price of $50.88 per share for a total of $5.09 million. Following the sale, the insider now owns 1.97 million shares.
Guardant Health Inc disclosed in a document filed with the SEC on Jun 18 ’25 that Tariq Musa (Director) sold a total of 3,213 shares of the company’s common stock. The trade occurred on Jun 18 ’25 and was made at $49.47 per share for $0.16 million. Following the transaction, the insider now directly holds 7190.0 shares of the GH stock.
Still, SEC filings show that on Jun 18 ’25, POTTER MYRTLE S (Director) disposed off 26 shares at an average price of $49.47 for $1286.0. The insider now directly holds 18,154 shares of Guardant Health Inc (GH).
